Found 20 matching trials
A Phase II, Randomized, Open-label Study of Lapatinib Plus Chemotherapy Versus Trastuzumab Plus Chemotherapy in HER2-positive and p95HER2-positive Metastatic Breast Cancer PHASE2 This is a Phase II, randomized, open-label, multi-center study evaluating t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study Evaluating the Efficacy and Safety of Lapatinib + Vinorelbine in ErbB2 Positive Metastatic Breast Cancer Patients PHASE2 The objective of this phase II study is to gain first information on the ef...
Show More Location
Dep. of Medicine I , Division of Oncology
Learn More & Join Trial
SYD985 vs. Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer PHASE3 The purpose of this study is to demonstrate that SYD985 \[(vic-)trastuzumab...
Show More Location
Southern Cancer Center
Learn More & Join Trial
Lapatinib in Combination With Oral Vinorelbine for Metastatic Breast Cancer PHASE1 Phase I part: to determine the recommended dose, and observe the preliminar...
Show More Location
Department of Oncology,National Taiwan University Hospital
Learn More & Join Trial
Lapatinib in Combination With Vinorelbine PHASE2 This is a randomized, parallel-arm, open-label, multi-centre, Phase II stud...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Dose Finding Study for Combination of Capecitabine, Lapatinib and Vinorelbine in Metastatic Breast Cancer PHASE1 The purpose of the study is to investigate safety and efficiency of the tri...
Show More Location
Onkologie Ravensburg
Learn More & Join Trial
A Multi-Center Study of Lapatinib in Patients With Trastuzumab-refractory Metastatic Breast Cancer PHASE2 Evaluating the Efficacy of Lapatinib in Combination With Chemotherapy in Pa...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial
DETECT III - A Multicenter, Phase III Study to Compare Standard Therapy +/- Lapatinib in HER2-ve MBC-Patients With HER2+ve CTCs PHASE3 The HER2 status in breast cancer patients may change during the course of t...
Show More Location
University Hospital Ulm
Learn More & Join Trial
Safety Study in Subjects With Metastatic Breast Cancer Who Progressed After Taxanes Treatment. PHASE2 Despite these initial positive signals in recent statistics, breast cancer ...
Show More Location
Dr. Guillermo Lerzo
Learn More & Join Trial
Chemotherapeutic Agents in Brain/Breast N/A RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Memorial Sloan Kettering
Learn More & Join Trial